Skip to content

Asset turnover at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×0.0×
Labcorp Holdings logo
Labcorp HoldingsLH
0.8×0.0×
Quest Diagnostics logo
Quest DiagnosticsDGX
0.7×0.0×
NeoGenomics logo
NeoGenomicsNEO
0.5×+0.1×
Natera, Inc. logo
Natera, Inc.NTRA
1.2×0.0×
Tempus AI, Inc. logo
Tempus AI, Inc.TEM
0.7×

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Calculated from Fulgent Genetics, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s asset turnover?
Fulgent Genetics, Inc. (FLGT) reported asset turnover of 0.3× in Q1 2026.
How has Fulgent Genetics, Inc.'s asset turnover changed year-over-year?
Fulgent Genetics, Inc.'s asset turnover increased by 13.0% year-over-year, from 0.2× to 0.3×.
What is the long-term trend for Fulgent Genetics, Inc.'s asset turnover?
Over 5 years (2020 to 2025), Fulgent Genetics, Inc.'s asset turnover has grown at a -24.3% compound annual growth rate (CAGR), from 1.1× to 0.3×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.